Information Library

Product Development & Commercialization - Managed Partnerships

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by:
  • Most Recent
  • Title

  • PHARMAXIS SELECTS QUINTILES TO COMMERCIALIZE BRONCHITOL

    August 31, 2010 – Quintiles announced a strategic agreement with Pharmaxis to provide a broad range of commercial solutions to support the European launch of Bronchitol®, an innovative treatment for cystic fibrosis.

  • Targeting Oncology

    June 2, 2010
    Learn more about Quintiles leadership in oncology product development and commercialization.

  • Focused Co-Promotion

    May 9, 2010
    Roche Italy needed to find new, cost-effective ways to underpin sales of mature products. Uncover what happened when a unique partnership with Quintiles reinforced sales growth.

  • Mapping the Future in Oncology Drug Development

    June 5, 2010
    Improving the development of oncology drugs is a high priority in order to enhance patient outcomes.

  • PharmAsia News Article Reprint

    March 1, 2010
    Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.

  • QUINTILES OPENS EXPANDED ASIA-PACIFIC HEADQUARTERS IN SINGAPORE

    November 6, 2009 - To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles announced the official grand opening of its expanded Asia-Pacific regional headquarters facility in Singapore's Science Park I.

  • QUINTILES ANNOUNCES CLINICAL RESEARCH PARNERSHIP WITH THE UNIVERSITY OF PRETORIA

    September 10, 2009 – Quintiles Prime Site Program expands into South Africa to accelerate clinical development.

  • Anatomy of a Managed Partnership

    May 26, 2009
    Partnering affords pharma the opportunity to bolster development pipelines without taking on additional risk or adding to fixed costs.

  • Gain Capital & Retain Value

    March 24, 2009
    Cell Therapeutics was in need of capital to fund ongoing development expenses, but was not interested in further equity dilution. As an alternative, they considered monetizing a royalty interest in Trisenox®, their only marketed oncology product.

  • Jumpstarting a Phase III Candidate

    March 24, 2009
    A global pharmaceutical company had a promising new formulation of a marketed product in early Phase III trials, but R&D budget pressures were likely to result in delays getting the product to market.

Page 1 of 1 (10 results)

Subscribe to Email Based on Your Interests

Set preferences